Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis

[1]  司履生.  Cancer epigenetics , 2006 .

[2]  Shuji Ogino,et al.  Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. , 2006, The Journal of molecular diagnostics : JMD.

[3]  M. Loda,et al.  CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.

[4]  H. Wanebo,et al.  Synchronous colon carcinomas: Molecular-genetic evidence for multicentricity , 1996, Annals of Surgical Oncology.

[5]  M. Loda,et al.  Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component , 2006, Modern Pathology.

[6]  E. Giovannucci,et al.  DNA methylation, field effects, and colorectal cancer. , 2005, Journal of the National Cancer Institute.

[7]  Gary L Rosner,et al.  Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.

[8]  Shuji Ogino,et al.  Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer , 2005, Clinical Cancer Research.

[9]  R. Wolff,et al.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.

[10]  S. SenGupta,et al.  The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers , 2005, British Journal of Cancer.

[11]  M. Loda,et al.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. , 2005, The Journal of molecular diagnostics : JMD.

[12]  A. Camargo,et al.  Colorectal cancer "methylator phenotype": fact or artifact? , 2005, Neoplasia.

[13]  M. Paz,et al.  Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. , 2005, Human molecular genetics.

[14]  Martin Widschwendter,et al.  Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen , 2004, Cancer Research.

[15]  M. Perucho,et al.  Genetics supersedes epigenetics in colon cancer phenotype. , 2003, Cancer cell.

[16]  D. Rothenberger,et al.  Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer , 2003, Cancer.

[17]  D. Bishop,et al.  Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas , 2003, Molecular pathology : MP.

[18]  B. Iacopetta,et al.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands , 2002, Gut.

[19]  R. Ward,et al.  CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. , 2002, Gastroenterology.

[20]  R. Ward,et al.  The Role of hMLH1 Methylation in the Development of Synchronous Sporadic Colorectal Carcinomas , 2002, Diseases of the colon and rectum.

[21]  W. Willett,et al.  The influence of folate and multivitamin use on the familial risk of colon cancer in women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  Jeffrey S. Morris,et al.  Concordant CpG island methylation in hyperplastic polyposis. , 2002, The American journal of pathology.

[23]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[24]  J. Herman,et al.  Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. , 2001, Cancer research.

[25]  P. Laird,et al.  Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version , 2001 .

[26]  A. Zauber,et al.  Molecular changes in the Ki‐ras and APC genes in colorectal adenomas and carcinomas arising in the same patient , 2001, The Journal of pathology.

[27]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[28]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. , 2000, Cancer research.

[29]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[30]  M. Fujishima,et al.  Discordance of P53 Mutations of Synchronous Colorectal Carcinomas , 2000, Modern Pathology.

[31]  N. Ahuja,et al.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[33]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Laird,et al.  CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.

[35]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[36]  J. Burke,et al.  Carcinoma of the colon and rectum. , 1962, The New England journal of medicine.